In PC-3 prostate cancer and melanoma cells, Neu2 activity has been correlated with invasive and metastastatic potential [65]; however, the biological substrates of Neu2 involved in this process remain to be identified. This evidence concerns the gene NEU2 and prostate carcinoma.